CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-10 | Chung Christine SVP, China Operations | Sale | −5,025 | $44.75 | $225K | 152,170 |
| 2019-07-10 | Chung Christine SVP, China Operations | Sale | −600 | $45.14 | $27K | 151,570 |
| 2019-07-10 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 8,959 | ||
| 2019-07-08 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $3.50 | $21K | 34,400 |
| 2019-07-08 | Kurkijarvi Kalevi Director | Sale | −4,600 | $42.35 | $195K | 29,800 |
| 2019-07-08 | Kurkijarvi Kalevi Director | Sale | −1,400 | $43.40 | $61K | 28,400 |
| 2019-07-08 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 6,000 | ||
| 2019-06-28 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Sale | −2,873 | $45.00 | $129K | 109,199 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Exercise or conversion | +6,834 | $2.90 | $20K | 2,437,540 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Sale | −16,200 | $44.28 | $717K | 2,421,340 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Sale | −2,200 | $45.22 | $99K | 2,419,140 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Sale | −1,318 | $44.23 | $58K | 55,682 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Sale | −100 | $45.45 | $5K | 55,582 |
| 2019-06-20 | Neff Thomas B Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,834 | 232,374 | ||
| 2019-06-19 | Neff Thomas B Chief Executive Officer | Exercise or conversion | +6,834 | $2.90 | $20K | 2,449,106 |
| 2019-06-19 | Neff Thomas B Chief Executive Officer | Sale | −18,400 | $44.02 | $810K | 2,430,706 |
| 2019-06-19 | Neff Thomas B Chief Executive Officer | Sale | −1,418 | $43.99 | $62K | 57,000 |
| 2019-06-19 | Neff Thomas B Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,834 | 239,208 | ||
| 2019-06-19 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $29.66 | $167K | 157,195 |
| 2019-06-19 | Chung Christine SVP, China Operations | Sale | −5,625 | $44.02 | $248K | 151,570 |
Page 31 of 33 · 651 trades